Costa CB et al. |
Farnesyltransferase inhibitors: molecular evidence of therapeutic efficacy in acute lymphoblastic leukemia through cyclin D1 inhibition. |
2012 |
Anticancer Res. |
pmid:22399601
|
Schlitzer M and Dahse HM |
Structure activity relationship of antiproliferative N-acyl-beta-alanine amides. |
2000 Nov-Dec |
Anticancer Res. |
pmid:11205283
|
Shirtliff ME et al. |
Farnesol-induced apoptosis in Candida albicans. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19364863
|
Chen F et al. |
Tooth-binding micelles for dental caries prevention. |
2009 |
Antimicrob. Agents Chemother. |
pmid:19704121
|
Brilhante RS et al. |
Effect of farnesol on growth, ergosterol biosynthesis, and cell permeability in Coccidioides posadasii. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23459491
|
Langford ML et al. |
Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions. |
2010 |
Antimicrob. Agents Chemother. |
pmid:19933803
|
Yu LH et al. |
Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22106223
|
Sharma M and Prasad R |
The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21768514
|
Brilhante RS et al. |
Sesquiterpene farnesol contributes to increased susceptibility to β-lactams in strains of Burkholderia pseudomallei. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22290941
|
Kostoulias X et al. |
Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26482299
|
Stoddart CA et al. |
Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25941222
|
Rossignol T et al. |
Transcriptional response of Candida parapsilosis following exposure to farnesol. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17684006
|
Hornby JM et al. |
Farnesol biosynthesis in Candida albicans: cellular response to sterol inhibition by zaragozic acid B. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12821501
|
Cao YY et al. |
cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15673737
|
Jabra-Rizk MA et al. |
Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16569866
|
Brehm-Stecher BF and Johnson EA |
Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone. |
2003 |
Antimicrob. Agents Chemother. |
pmid:14506058
|
Falsetta ML et al. |
Novel antibiofilm chemotherapy targets exopolysaccharide synthesis and stress tolerance in Streptococcus mutans to modulate virulence expression in vivo. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22985885
|
Dumitru R et al. |
Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15215080
|
Rodrigues Goulart H et al. |
Terpenes arrest parasite development and inhibit biosynthesis of isoprenoids in Plasmodium falciparum. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15215101
|
Hornby JM and Nickerson KW |
Enhanced production of farnesol by Candida albicans treated with four azoles. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15155241
|